Key points are not available for this paper at this time.
Owing to the unique ability of antibodies that bind the membrane proximal region of the extracellular domain to trigger conformational changes leading to affinity modulation and homophilic adhesion strengthening, PECAM-1 might be an attractive target for treating vascular permeability disorders.
Lertkiatmongkol et al. (Sat,) studied this question.